CLAYTON, Mo. , March 03, 2017 -- FutureFuel Corp. (NYSE:FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release year-end 2016 financial results after market close on Thursday, March 16, 2017.
About FutureFuel
FutureFuel is a leading manufacturer of diversified chemical products and biofuels. FutureFuel’s chemicals segment manufactures specialty chemicals for specific customers (“custom manufacturing”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom manufacturing product portfolio includes a laundry detergent additive, proprietary agrochemicals, adhesion promoters, a biocide intermediate, and an antioxidant precursor. FutureFuel’s performance chemicals products include a portfolio of proprietary nylon and polyester polymer modifiers and several small-volume specialty chemicals and solvents for diverse applications. FutureFuel’s biofuels segment primarily produces and sells biodiesel to its customers. Please visit www.futurefuelcorporation.com for more information.
COMPANY CONTACT: FutureFuel Corp. Paul M. Flynn (314) 854-8385 www.futurefuelcorporation.com


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



